Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.
about
N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in ratsThe Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary VasculatureNuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species.Correlation between nuclear factor κB activity and pulmonary artery pressure in a rat high pulmonary blood flow model.The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.BMP pathway regulation of and by macrophages.Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling PathwayTranscription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension.Mechanism by which nuclear factor-kappa beta (NF-kB) regulates ovine fetal pulmonary vascular smooth muscle cell proliferation.Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension.Utility of Hepatocyte Growth Factor as a Biomarker for Early Diagnosis of Pulmonary Artery Hypertension.
P2860
Q33786092-F240270B-C6A9-45EB-ABE3-334512D972FFQ33804336-BB5D896C-4E08-4BB5-9049-5AF0E59E599BQ34305561-5423F1C5-4402-4F57-8C7D-5DC158F0F653Q34495667-23628211-61D9-41BB-B945-8E139A889FF2Q34795531-C37BE443-D5AC-4A31-BB33-035448DCB29DQ35115789-79F62573-82FB-4268-BF23-5A2108C8128CQ35142695-46681E4A-A349-4CDB-A93A-E8E6FA404EF5Q35779717-86C78B86-A75F-4557-A31E-154C05CF7FB6Q35859481-E6919697-AC34-43EB-AF75-375F0095B620Q37555457-EF6FA267-E872-4D14-B337-D6B32C113FBBQ37561236-F2AFC125-0CC6-447D-AC2B-3DA640E7965EQ38772293-EB1EE2DB-D6B6-4EB9-A387-83AFE30F08ACQ46280900-065D7413-3C8C-4DC8-A4B6-CA271054F9C8Q51683026-58E71F53-5A35-4152-A0EF-B5DF812E8794
P2860
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nuclear factor κ-B is activate ...... lmonary arterial hypertension.
@en
Nuclear factor κ-B is activate ...... lmonary arterial hypertension.
@nl
type
label
Nuclear factor κ-B is activate ...... lmonary arterial hypertension.
@en
Nuclear factor κ-B is activate ...... lmonary arterial hypertension.
@nl
prefLabel
Nuclear factor κ-B is activate ...... lmonary arterial hypertension.
@en
Nuclear factor κ-B is activate ...... lmonary arterial hypertension.
@nl
P2093
P2860
P50
P1433
P1476
Nuclear factor κ-B is activate ...... ulmonary arterial hypertension
@en
P2093
Alastair Proudfoot
Barbara Girerd
Dongmin Shao
Gaetano Caramori
Laura C Price
Mark Griffiths
Natalia Gambaryan
Paolo Casolari
P2860
P304
P356
10.1371/JOURNAL.PONE.0075415
P407
P50
P577
2013-10-04T00:00:00Z